nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Paclitaxel—ovarian cancer	0.106	0.138	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.106	0.138	CbGbCtD
Dextropropoxyphene—CYP3A7—Docetaxel—ovarian cancer	0.0764	0.0998	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0764	0.0998	CbGbCtD
Dextropropoxyphene—CYP2C8—Paclitaxel—ovarian cancer	0.0762	0.0996	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinorelbine—ovarian cancer	0.0692	0.0904	CbGbCtD
Dextropropoxyphene—CYP3A4—Topotecan—ovarian cancer	0.0624	0.0816	CbGbCtD
Dextropropoxyphene—CYP2C9—Paclitaxel—ovarian cancer	0.0531	0.0695	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinorelbine—ovarian cancer	0.044	0.0575	CbGbCtD
Dextropropoxyphene—CYP3A4—Paclitaxel—ovarian cancer	0.0309	0.0404	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—ovarian cancer	0.0262	0.0342	CbGbCtD
Dextropropoxyphene—CYP3A4—Docetaxel—ovarian cancer	0.0223	0.0292	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—ovarian cancer	0.0167	0.0218	CbGbCtD
Dextropropoxyphene—Cardiac disorder—Vinorelbine—ovarian cancer	0.00118	0.00512	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Paclitaxel—ovarian cancer	0.00118	0.0051	CcSEcCtD
Dextropropoxyphene—Toremifene—ESR1—ovarian cancer	0.00117	0.251	CrCbGaD
Dextropropoxyphene—Ataxia—Paclitaxel—ovarian cancer	0.00116	0.00504	CcSEcCtD
Dextropropoxyphene—Liver injury—Epirubicin—ovarian cancer	0.00116	0.00502	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Docetaxel—ovarian cancer	0.00116	0.00501	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Vinorelbine—ovarian cancer	0.00115	0.00498	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00115	0.00497	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00114	0.00495	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Vinorelbine—ovarian cancer	0.00114	0.00493	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00111	0.00481	CcSEcCtD
Dextropropoxyphene—Malnutrition—Vinorelbine—ovarian cancer	0.00111	0.0048	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Docetaxel—ovarian cancer	0.00111	0.0048	CcSEcCtD
Dextropropoxyphene—Convulsion—Melphalan—ovarian cancer	0.0011	0.00476	CcSEcCtD
Dextropropoxyphene—Discomfort—Topotecan—ovarian cancer	0.00109	0.00472	CcSEcCtD
Dextropropoxyphene—Liver injury—Doxorubicin—ovarian cancer	0.00107	0.00464	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00105	0.00455	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Chlorambucil—ovarian cancer	0.00104	0.00453	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Topotecan—ovarian cancer	0.00104	0.00449	CcSEcCtD
Dextropropoxyphene—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00103	0.00445	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00102	0.00444	CcSEcCtD
Dextropropoxyphene—Tachycardia—Melphalan—ovarian cancer	0.00101	0.00438	CcSEcCtD
Dextropropoxyphene—Ataxia—Docetaxel—ovarian cancer	0.000985	0.00427	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Chlorambucil—ovarian cancer	0.000977	0.00424	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—ovarian cancer	0.000974	0.00422	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00097	0.00421	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Docetaxel—ovarian cancer	0.000967	0.0042	CcSEcCtD
Dextropropoxyphene—Hypotension—Melphalan—ovarian cancer	0.000966	0.00419	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Topotecan—ovarian cancer	0.000941	0.00408	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000939	0.00407	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Chlorambucil—ovarian cancer	0.000938	0.00407	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Paclitaxel—ovarian cancer	0.000934	0.00405	CcSEcCtD
Dextropropoxyphene—Discomfort—Vinorelbine—ovarian cancer	0.000931	0.00404	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Topotecan—ovarian cancer	0.000929	0.00403	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Melphalan—ovarian cancer	0.000922	0.004	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000912	0.00396	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Melphalan—ovarian cancer	0.00091	0.00395	CcSEcCtD
Dextropropoxyphene—Constipation—Topotecan—ovarian cancer	0.000903	0.00392	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000901	0.00391	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000901	0.00391	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000893	0.00387	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—ovarian cancer	0.00089	0.00386	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Vinorelbine—ovarian cancer	0.000886	0.00384	CcSEcCtD
Dextropropoxyphene—Tachycardia—Vinorelbine—ovarian cancer	0.000882	0.00382	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Chlorambucil—ovarian cancer	0.000874	0.00379	CcSEcCtD
Dextropropoxyphene—Bradycardia—Paclitaxel—ovarian cancer	0.000871	0.00378	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Topotecan—ovarian cancer	0.00087	0.00378	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Topotecan—ovarian cancer	0.000863	0.00375	CcSEcCtD
Dextropropoxyphene—Asthenia—Chlorambucil—ovarian cancer	0.000851	0.00369	CcSEcCtD
Dextropropoxyphene—Hypotension—Vinorelbine—ovarian cancer	0.000844	0.00366	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Topotecan—ovarian cancer	0.000835	0.00362	CcSEcCtD
Dextropropoxyphene—Visual impairment—Paclitaxel—ovarian cancer	0.000824	0.00358	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—ovarian cancer	0.000823	0.00357	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Chlorambucil—ovarian cancer	0.000812	0.00352	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000809	0.00351	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Vinorelbine—ovarian cancer	0.000805	0.00349	CcSEcCtD
Dextropropoxyphene—Eye disorder—Paclitaxel—ovarian cancer	0.000799	0.00347	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000796	0.00345	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Paclitaxel—ovarian cancer	0.000794	0.00344	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Docetaxel—ovarian cancer	0.000791	0.00343	CcSEcCtD
Dextropropoxyphene—Jaundice—Docetaxel—ovarian cancer	0.000787	0.00341	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00078	0.00338	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000779	0.00338	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Topotecan—ovarian cancer	0.000778	0.00338	CcSEcCtD
Dextropropoxyphene—Constipation—Vinorelbine—ovarian cancer	0.000772	0.00335	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Paclitaxel—ovarian cancer	0.000772	0.00335	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000771	0.00334	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Paclitaxel—ovarian cancer	0.000764	0.00331	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000764	0.00331	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Melphalan—ovarian cancer	0.000762	0.0033	CcSEcCtD
Dextropropoxyphene—Asthenia—Topotecan—ovarian cancer	0.000758	0.00329	CcSEcCtD
Dextropropoxyphene—Vomiting—Chlorambucil—ovarian cancer	0.000754	0.00327	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000748	0.00325	CcSEcCtD
Dextropropoxyphene—Malnutrition—Paclitaxel—ovarian cancer	0.000744	0.00323	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Vinorelbine—ovarian cancer	0.000744	0.00323	CcSEcCtD
Dextropropoxyphene—Asthenia—Melphalan—ovarian cancer	0.000742	0.00322	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000739	0.0032	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Topotecan—ovarian cancer	0.000722	0.00313	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000721	0.00313	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vinorelbine—ovarian cancer	0.000714	0.0031	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Melphalan—ovarian cancer	0.000707	0.00307	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000707	0.00307	CcSEcCtD
Dextropropoxyphene—Nausea—Chlorambucil—ovarian cancer	0.000705	0.00306	CcSEcCtD
Dextropropoxyphene—Vision blurred—Paclitaxel—ovarian cancer	0.000702	0.00304	CcSEcCtD
Dextropropoxyphene—Visual impairment—Docetaxel—ovarian cancer	0.000699	0.00303	CcSEcCtD
Dextropropoxyphene—Dizziness—Topotecan—ovarian cancer	0.000698	0.00303	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1B1—ovarian cancer	0.000691	0.149	CrCbGaD
Dextropropoxyphene—Agitation—Paclitaxel—ovarian cancer	0.000684	0.00297	CcSEcCtD
Dextropropoxyphene—Eye disorder—Docetaxel—ovarian cancer	0.000677	0.00294	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Docetaxel—ovarian cancer	0.000673	0.00292	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—ovarian cancer	0.000672	0.00292	CcSEcCtD
Dextropropoxyphene—Vomiting—Topotecan—ovarian cancer	0.000671	0.00291	CcSEcCtD
Dextropropoxyphene—Syncope—Paclitaxel—ovarian cancer	0.000668	0.0029	CcSEcCtD
Dextropropoxyphene—Rash—Topotecan—ovarian cancer	0.000666	0.00289	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vinorelbine—ovarian cancer	0.000666	0.00289	CcSEcCtD
Dextropropoxyphene—Dermatitis—Topotecan—ovarian cancer	0.000665	0.00289	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—ovarian cancer	0.000665	0.00288	CcSEcCtD
Dextropropoxyphene—Headache—Topotecan—ovarian cancer	0.000661	0.00287	CcSEcCtD
Dextropropoxyphene—Vomiting—Melphalan—ovarian cancer	0.000657	0.00285	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Docetaxel—ovarian cancer	0.000655	0.00284	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Paclitaxel—ovarian cancer	0.000654	0.00284	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000654	0.00284	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Docetaxel—ovarian cancer	0.000653	0.00283	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—ovarian cancer	0.000652	0.00283	CcSEcCtD
Dextropropoxyphene—Rash—Melphalan—ovarian cancer	0.000652	0.00283	CcSEcCtD
Dextropropoxyphene—Dermatitis—Melphalan—ovarian cancer	0.000651	0.00283	CcSEcCtD
Dextropropoxyphene—Asthenia—Vinorelbine—ovarian cancer	0.000648	0.00281	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Docetaxel—ovarian cancer	0.000648	0.00281	CcSEcCtD
Dextropropoxyphene—Convulsion—Paclitaxel—ovarian cancer	0.000645	0.0028	CcSEcCtD
Dextropropoxyphene—Malnutrition—Docetaxel—ovarian cancer	0.000631	0.00274	CcSEcCtD
Dextropropoxyphene—Nausea—Topotecan—ovarian cancer	0.000627	0.00272	CcSEcCtD
Dextropropoxyphene—Discomfort—Paclitaxel—ovarian cancer	0.000626	0.00272	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—ovarian cancer	0.000622	0.0027	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vinorelbine—ovarian cancer	0.000618	0.00268	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—ovarian cancer	0.000615	0.00267	CcSEcCtD
Dextropropoxyphene—Nausea—Melphalan—ovarian cancer	0.000614	0.00266	CcSEcCtD
Dextropropoxyphene—Confusional state—Paclitaxel—ovarian cancer	0.000613	0.00266	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000604	0.00262	CcSEcCtD
Dextropropoxyphene—Shock—Paclitaxel—ovarian cancer	0.000598	0.00259	CcSEcCtD
Dextropropoxyphene—Dizziness—Vinorelbine—ovarian cancer	0.000597	0.00259	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Paclitaxel—ovarian cancer	0.000596	0.00259	CcSEcCtD
Dextropropoxyphene—Tachycardia—Paclitaxel—ovarian cancer	0.000593	0.00257	CcSEcCtD
Dextropropoxyphene—Vomiting—Vinorelbine—ovarian cancer	0.000574	0.00249	CcSEcCtD
Dextropropoxyphene—Rash—Vinorelbine—ovarian cancer	0.00057	0.00247	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vinorelbine—ovarian cancer	0.000569	0.00247	CcSEcCtD
Dextropropoxyphene—Hypotension—Paclitaxel—ovarian cancer	0.000568	0.00246	CcSEcCtD
Dextropropoxyphene—Headache—Vinorelbine—ovarian cancer	0.000566	0.00246	CcSEcCtD
Dextropropoxyphene—Syncope—Docetaxel—ovarian cancer	0.000566	0.00245	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Docetaxel—ovarian cancer	0.000555	0.00241	CcSEcCtD
Dextropropoxyphene—Insomnia—Paclitaxel—ovarian cancer	0.00055	0.00238	CcSEcCtD
Dextropropoxyphene—Convulsion—Docetaxel—ovarian cancer	0.000547	0.00237	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—ovarian cancer	0.000545	0.00236	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Paclitaxel—ovarian cancer	0.000542	0.00235	CcSEcCtD
Dextropropoxyphene—Somnolence—Paclitaxel—ovarian cancer	0.00054	0.00234	CcSEcCtD
Dextropropoxyphene—Nausea—Vinorelbine—ovarian cancer	0.000537	0.00233	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Paclitaxel—ovarian cancer	0.000535	0.00232	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—ovarian cancer	0.000531	0.0023	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000525	0.00228	CcSEcCtD
Dextropropoxyphene—Constipation—Paclitaxel—ovarian cancer	0.00052	0.00225	CcSEcCtD
Dextropropoxyphene—Confusional state—Docetaxel—ovarian cancer	0.000519	0.00225	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000515	0.00223	CcSEcCtD
Dextropropoxyphene—Shock—Docetaxel—ovarian cancer	0.000507	0.0022	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Docetaxel—ovarian cancer	0.000505	0.00219	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—ovarian cancer	0.000504	0.00219	CcSEcCtD
Dextropropoxyphene—Tachycardia—Docetaxel—ovarian cancer	0.000503	0.00218	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Paclitaxel—ovarian cancer	0.000501	0.00217	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—ovarian cancer	0.000498	0.00216	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000497	0.00216	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—ovarian cancer	0.000497	0.107	CrCbGaD
Dextropropoxyphene—Jaundice—Doxorubicin—ovarian cancer	0.000491	0.00213	CcSEcCtD
Dextropropoxyphene—Hypotension—Docetaxel—ovarian cancer	0.000481	0.00209	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Paclitaxel—ovarian cancer	0.00048	0.00208	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000477	0.00207	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—ovarian cancer	0.000471	0.00204	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR1—ovarian cancer	0.000467	0.1	CrCbGaD
Dextropropoxyphene—Insomnia—Docetaxel—ovarian cancer	0.000466	0.00202	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—ovarian cancer	0.000461	0.002	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Docetaxel—ovarian cancer	0.000459	0.00199	CcSEcCtD
Dextropropoxyphene—Somnolence—Docetaxel—ovarian cancer	0.000458	0.00199	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—ovarian cancer	0.000457	0.00198	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—ovarian cancer	0.000454	0.00197	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Docetaxel—ovarian cancer	0.000453	0.00197	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Paclitaxel—ovarian cancer	0.000448	0.00194	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000445	0.00193	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—ovarian cancer	0.000442	0.00192	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—ovarian cancer	0.000441	0.00191	CcSEcCtD
Dextropropoxyphene—Constipation—Docetaxel—ovarian cancer	0.00044	0.00191	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—ovarian cancer	0.000437	0.00189	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—ovarian cancer	0.000436	0.00189	CcSEcCtD
Dextropropoxyphene—Asthenia—Paclitaxel—ovarian cancer	0.000436	0.00189	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—ovarian cancer	0.000426	0.00185	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Docetaxel—ovarian cancer	0.000424	0.00184	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—ovarian cancer	0.000423	0.00183	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000421	0.00183	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—ovarian cancer	0.00042	0.00182	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Paclitaxel—ovarian cancer	0.000416	0.0018	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—ovarian cancer	0.000409	0.00177	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000408	0.00177	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Docetaxel—ovarian cancer	0.000407	0.00177	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—ovarian cancer	0.000404	0.00175	CcSEcCtD
Dextropropoxyphene—Dizziness—Paclitaxel—ovarian cancer	0.000402	0.00174	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—ovarian cancer	0.000401	0.00174	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—ovarian cancer	0.000394	0.00171	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—ovarian cancer	0.000391	0.0017	CcSEcCtD
Dextropropoxyphene—Vomiting—Paclitaxel—ovarian cancer	0.000386	0.00168	CcSEcCtD
Dextropropoxyphene—Rash—Paclitaxel—ovarian cancer	0.000383	0.00166	CcSEcCtD
Dextropropoxyphene—Dermatitis—Paclitaxel—ovarian cancer	0.000383	0.00166	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—ovarian cancer	0.000382	0.00166	CcSEcCtD
Dextropropoxyphene—Headache—Paclitaxel—ovarian cancer	0.000381	0.00165	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Docetaxel—ovarian cancer	0.000379	0.00165	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—ovarian cancer	0.000374	0.00162	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—ovarian cancer	0.000371	0.00161	CcSEcCtD
Dextropropoxyphene—Asthenia—Docetaxel—ovarian cancer	0.000369	0.0016	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—ovarian cancer	0.000369	0.0016	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—ovarian cancer	0.000362	0.00157	CcSEcCtD
Dextropropoxyphene—Nausea—Paclitaxel—ovarian cancer	0.000361	0.00157	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—ovarian cancer	0.000358	0.00155	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—ovarian cancer	0.000353	0.00153	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Docetaxel—ovarian cancer	0.000352	0.00153	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—ovarian cancer	0.00035	0.00152	CcSEcCtD
Dextropropoxyphene—Propafenone—ABCB1—ovarian cancer	0.00035	0.0753	CrCbGaD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—ovarian cancer	0.000346	0.0015	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—ovarian cancer	0.000342	0.00148	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—ovarian cancer	0.000341	0.00148	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—ovarian cancer	0.000341	0.00148	CcSEcCtD
Dextropropoxyphene—Dizziness—Docetaxel—ovarian cancer	0.000341	0.00148	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—ovarian cancer	0.000339	0.00147	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—ovarian cancer	0.000331	0.00144	CcSEcCtD
Dextropropoxyphene—Vomiting—Docetaxel—ovarian cancer	0.000327	0.00142	CcSEcCtD
Dextropropoxyphene—Rash—Docetaxel—ovarian cancer	0.000325	0.00141	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—ovarian cancer	0.000325	0.00141	CcSEcCtD
Dextropropoxyphene—Dermatitis—Docetaxel—ovarian cancer	0.000324	0.00141	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—ovarian cancer	0.000324	0.00141	CcSEcCtD
Dextropropoxyphene—Headache—Docetaxel—ovarian cancer	0.000323	0.0014	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—ovarian cancer	0.000316	0.00137	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—ovarian cancer	0.000315	0.00137	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—ovarian cancer	0.000314	0.00136	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—ovarian cancer	0.000314	0.00136	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—ovarian cancer	0.000312	0.0671	CrCbGaD
Dextropropoxyphene—Dyspnoea—Epirubicin—ovarian cancer	0.00031	0.00134	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—ovarian cancer	0.000309	0.00134	CcSEcCtD
Dextropropoxyphene—Nausea—Docetaxel—ovarian cancer	0.000306	0.00133	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—ovarian cancer	0.000306	0.00133	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—ovarian cancer	0.0003	0.0013	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.0003	0.0013	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—ovarian cancer	0.000297	0.00129	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—ovarian cancer	0.000291	0.00126	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—ovarian cancer	0.000287	0.0617	CrCbGaD
Dextropropoxyphene—Dyspnoea—Doxorubicin—ovarian cancer	0.000287	0.00124	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—ovarian cancer	0.000286	0.00124	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—ovarian cancer	0.000286	0.00124	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000284	0.00123	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—ovarian cancer	0.000283	0.00123	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000277	0.0012	CcSEcCtD
Dextropropoxyphene—Loperamide—ABCB1—ovarian cancer	0.000276	0.0594	CrCbGaD
Dextropropoxyphene—Constipation—Doxorubicin—ovarian cancer	0.000275	0.00119	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—ovarian cancer	0.000275	0.00119	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—ovarian cancer	0.000265	0.00115	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000263	0.00114	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—ovarian cancer	0.000256	0.00111	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—ovarian cancer	0.000254	0.0011	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—ovarian cancer	0.000249	0.00108	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—ovarian cancer	0.000238	0.00103	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—ovarian cancer	0.000237	0.00103	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—ovarian cancer	0.000231	0.001	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—ovarian cancer	0.00023	0.000997	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—ovarian cancer	0.000221	0.000958	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—ovarian cancer	0.00022	0.000954	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—ovarian cancer	0.000219	0.00095	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—ovarian cancer	0.000219	0.000949	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—ovarian cancer	0.000218	0.000944	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—ovarian cancer	0.000213	0.000922	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—ovarian cancer	0.000208	0.0446	CrCbGaD
Dextropropoxyphene—Nausea—Epirubicin—ovarian cancer	0.000206	0.000895	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—ovarian cancer	0.000204	0.000887	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—ovarian cancer	0.000203	0.000879	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—ovarian cancer	0.000202	0.000878	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—ovarian cancer	0.000201	0.000874	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCB1—ovarian cancer	0.000198	0.0427	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—ovarian cancer	0.000197	0.0423	CrCbGaD
Dextropropoxyphene—Nausea—Doxorubicin—ovarian cancer	0.000191	0.000828	CcSEcCtD
